Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 3, 2000, Pages 567-574

  Kupelian, Patrick A ^a   Mohan, Dasarahally S ^a   Lyons, Janice ^a   Klein, Eric A ^a   Reddy, Chandana A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hormonal therapy; Localized prostate cancer; Radiation dose; Radiotherapy; Treatment

Indexed keywords

ANDROGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS; TREATMENT FAILURE;

EID: 0033982780     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00455-1     Document Type: Article

References (14)

1. Hanks G.E., Hanlon A.L., Pinover W.H., Horvitz E.M. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Scientif Amer. 5:1999;152-158.
2. Hanks G.E., Hanlon A.L., Schultheiss T.E., Pinover W.H., Movsas B., Epstein B.E., Hunt M.A. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
3. Kupelian P.A. Improvement in overall survival for patients with localized prostate cancer with higher than standard radiation doses Preliminary results . J Urol. 161:1999;386.
4. Lyons J., Kupelian P. Importance of radiation dose in the treatment of stage T1-T2 adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 42:(Suppl. 1):1998;308.
5. Pollack A., Zagars G.K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 39:1997;1011-1108.
6. Zelefsky M.J., Leibel S.A., Gaudin P.B., Kutcher G.J., Fleshner N.E., Venkatramen E.S., Reuter V.E., Fair W.R., Ling C.C., Fuks Z. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
7. Zelefsky M.J., Leibel S.A., Kutcher G.J., Fuks Z. Three-dimensional conformal radiotherapy and dose escalation Where do we stand? Semin Radiat Oncol. 8:1998;107-114.
8. Pollack A., Zagars G., Starkshall G., Chidress C., Kopplin S., Boyer A., Rosen I. Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
9. Katcher J., Kupelian P.A., Zippe C., Klein E.A., Sohn J.W. Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys. 37:1997;871-876.
10. Pollack A., Zagars G.K. External beam radiotherapy for stage T1/T2 prostate cancer How does it stack up? Urology. 51:1998;258-264.
11. Stock R.G., Stone N.N., Tabert A., Iannuzzi C., DeWyngaert J.K. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys. 41:1998;101-108.
12. Hanlon A.L., Schultheiss T.E., Hunt M.A., Movsas B., Peter R.S., Hanks G.E. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
13. Nguyen L.N., Pollack A., Zagars G.K. Late effects after radiotherapy for prostate cancer in a randomized dose-response study Results of a self-assessment questionnaire . Urology. 51:1998;991-997.
14. Zelefsky M.J., Fuks Z., Wolfe T., Kutcher G.J., Burman C., Ling C.C., Venkatraman E.S., Leibel S.A. Locally advanced prostatic cancer Long-term toxicity outcome after three-dimensional conformal radiation therapy - a dose-escalation study . Radiology. 209:1998;169-174.